# Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting

> **NCT05694858** · PHASE1,PHASE2 · RECRUITING · sponsor: **Universiti Kebangsaan Malaysia Medical Centre** · enrollment: 154 (estimated)

## Conditions studied

- Glaucoma
- Cataract
- Ophthalmological Disorder

## Interventions

- **COMBINATION_PRODUCT:** Lignocaine-loaded maltose microneedle array patch
- **DRUG:** EMLA 5% patch

## Key facts

- **NCT ID:** NCT05694858
- **Lead sponsor:** Universiti Kebangsaan Malaysia Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2026-12-11
- **Final completion:** 2026-12-11
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05694858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05694858, "Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05694858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*